BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15518130)

  • 1. [Septic shock following intracavitary Bacillus Calmette-Guerin therapy for postcystectomy ureteral cancer].
    Ishida K; Yuhara K; Kanimoto Y
    Hinyokika Kiyo; 2004 Sep; 50(9):633-6. PubMed ID: 15518130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two cases of successful treatments with steroid for local and systemic hypersensitivity reaction following intravesical instillation of Bacillus Calmette-Guerin].
    Shimasaki N; Yamasaki I; Kamada M; Syuin T
    Hinyokika Kiyo; 2001 Apr; 47(4):281-4. PubMed ID: 11411106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Squamous cell carcinoma of the urinary bladder after intravesical bacillus Calmette-Guerin therapy for carcinoma in situ: a case report].
    Uemura M; Nishimura K; Nakagawa M; Kanno N; Miyoshi S; Kawano K; Inoue H
    Hinyokika Kiyo; 2004 Nov; 50(11):809-11. PubMed ID: 15628544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of transitional cell carcinoma with squamous differentiation which developed squamous cell carcinoma in situ in the clinical course].
    Sugiura S; Makiyama K; Yokomizo Y; Umemoto S; Miyoshi Y; Nakaigawa N; Ogawa T; Uemurai H; Yao M; Kubota Y; Yamanaka S
    Hinyokika Kiyo; 2006 Sep; 52(9):715-8. PubMed ID: 17040058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical site infection by bacillus Calmette-Guerin (BCG) after radical cystectomy, occurring after intravesical bcg therapy: a case report].
    Muranaka T; Kunishima Y; Shigyo M; Kato R; Masumori N; Ito N; Tsukamoto T; Takagi Y; Seki M; Toida I
    Hinyokika Kiyo; 2007 Aug; 53(8):581-4. PubMed ID: 17874552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K; Chihara Y; Kondo H; Hirao Y
    Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transitional cell carcinoma in prostate after intravesical instillation of Bacillus Calmette-Guerin].
    Ito Y; Nishiyama H; Higashi S; Kinoshita H; Ito N; Yamamoto S; Kamoto T; Ogawa O
    Hinyokika Kiyo; 2004 May; 50(5):335-8. PubMed ID: 15237488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Squamous cell carcinoma of the renal pelvis after intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of upper urinary tract: a case report].
    Uemura M; Mukai M; Fukuhara S; Kanno N; Nishimura K; Miyoshi S; Yoshida K; Kawano K; Inoue H; Nishimura K
    Hinyokika Kiyo; 2002 Jun; 48(6):355-7. PubMed ID: 12166236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical bacillus Calmette-Guérin therapy for T1 superficial bladder cancer.
    Demkow T; Alter A; Wiechno P
    Urol Int; 2008; 80(1):74-9. PubMed ID: 18204238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
    Steinbach F; Schuster F
    Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bilateral tuberculous epididymitis after intravesical Bacillus Calmette-Guerin therapy].
    Shigehara K; Kobori Y; Amano T; Takemae K
    Hinyokika Kiyo; 2005 Dec; 51(12):839-42. PubMed ID: 16440736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of tuberculous epididymitis caused by intravesical BCG therapy].
    Koizumi T; Nakanishi R; Taue R; Yamaguchi K; Nakatuji H; Kishimoto T; Izaki H; Oka N; Takahashi M; Fukumori T; Kanayama HO
    Hinyokika Kiyo; 2008 Sep; 54(9):625-7. PubMed ID: 18975579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Only metastasis to uterine corpus from superficial bladder cancer that of no original recurrence].
    Murakami T; Hoshino K; Hasumi H; Makiyama K; Miyoshi Y; Yoshida M; Nakaigawa N; Ogawa T; Uemura H; Yao M; Kubota Y
    Hinyokika Kiyo; 2007 Jan; 53(1):75-7. PubMed ID: 17310775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic cystitis induced by bacillus Calmette-Guerin (BCG) intravesical instillation.
    Hidoussi A; Slama A; Jaidane M; Zakhama W; Youssef A; Ben Sorba N; Mosbah AF
    Urology; 2007 Sep; 70(3):591.e9-10. PubMed ID: 17905131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
    Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y
    Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of bacillus Calmette-Guerin (BCG) immunotherapy in superficial bladder cancer.
    Sosnowski JT
    Compr Ther; 1994; 20(12):695-701. PubMed ID: 7882653
    [No Abstract]   [Full Text] [Related]  

  • 20. [Assessment of 8-hydroxy-2'-deoxyguanosine concentrations in bladder cancer patients treated with intravesical BCG instillation].
    Kaczmarek P; Błaszczyk J; Fijałkowski P; Sierakowska-Fijałek A; Niemirowicz J; Kasprzak A; Baj Z
    Pol Merkur Lekarski; 2005 Oct; 19(112):526-8. PubMed ID: 16379317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.